The Ensuring Access to Clinical Trials Act, introduced by Representative Lloyd Doggett, allows patients with rare diseases to participate in and benefit from clinical trials without risk of losing critical benefits.
Green describes Doggett's bill aimed at supporting patients with rare diseases.
Share
More from Gene Green
I would like to thank Dr. Rucker for testifying today on the Office of National Coordinator's work to implement the 21st Century Cures Act.
I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.
Harris Health uses the savings from the program on patient care services which include the cost of treatment, administration, management of services and facilities, and improves access to quality health care for our community.
I am extremely disappointed that 2 years after the passage of Cures we still do not have the regulations necessary to implement these provisions.
Other voices in this conversation
